AIMS: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. DESIGN: Cross-sectional analysis of subjects seeking SUD treatment. SETTING: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. PARTICIPANTS: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. MEASUREMENTS: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. FINDINGS: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. CONCLUSIONS: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.
AIMS: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. DESIGN: Cross-sectional analysis of subjects seeking SUD treatment. SETTING: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. PARTICIPANTS: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. MEASUREMENTS: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. FINDINGS: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. CONCLUSIONS: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.
Authors: T L Patterson; R M Kaplan; I Grant; S J Semple; S Moscona; W L Koch; M J Harris; D V Jeste Journal: Psychiatry Res Date: 1996-07-31 Impact factor: 3.222
Authors: G Richard Smith; M Audrey Burnam; Cynthia L Mosley; Jan A Hollenberg; Mike Mancino; Wen Grimes Journal: Psychiatr Serv Date: 2006-10 Impact factor: 3.084
Authors: Jeffrey M Pyne; Shanti Tripathi; Michael French; Kathryn McCollister; Richard C Rapp; Brenda M Booth Journal: Addiction Date: 2011-03 Impact factor: 6.526
Authors: Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman Journal: Addiction Date: 2015-12-17 Impact factor: 6.526
Authors: Joshua A Barocas; Abriana Tasillo; Golnaz Eftekhari Yazdi; Jianing Wang; Claudia Vellozzi; Susan Hariri; Cheryl Isenhour; Liisa Randall; John W Ward; Jonathan Mermin; Joshua A Salomon; Benjamin P Linas Journal: Clin Infect Dis Date: 2018-08-01 Impact factor: 20.999
Authors: S Schawo; C Bouwmans; E van der Schee; V Hendriks; W Brouwer; L Hakkaart Journal: Health Qual Life Outcomes Date: 2017-09-19 Impact factor: 3.186
Authors: Holly N Essex; Ian R White; Zarnie Khadjesari; Stuart Linke; Jim McCambridge; Elizabeth Murray; Steve Parrott; Christine Godfrey Journal: Qual Life Res Date: 2013-09-13 Impact factor: 4.147